Regencell Bioscience Holdings Ltd. RGC
NASDAQ · United States · Health Technology
$6.36+0.14 (+2.17%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Momentum and volatility snapshot
| Average | Value | Price vs. average |
|---|---|---|
| 20-period average | $6.07 | +4.61% · above |
| 50-period average | $5.79 | +9.79% · above |
| 200-period average | $19.21 | -66.91% · below |
| Avg. volume (1Y) | 267.40K |
Total return, dividends included.
All indicators are computed from the last year of daily closes. Returns and volatility use the dividend-adjusted series; averages and highs/lows use the traded price. Not investment advice.